DataKnowledgeCloudtrainingcoordination

maintaining cell culture (Sample Prep Method)

Description:a protocol application in which cells are kept alive in a defined environment outside of an organism. part of cell_culturing

Results found

Linked to

	Label	Description
	L1000 LINCS DCIC 2021 PBIOA015 HCC515 24H G18 bortezomib 10uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC XPR002 HELA.311 96H I15 AKT2 2.00uL Biosample (Entity type)	A biosample from LINCS produced as part of the L1000 Phase2 project
	L1000 LINCS DCIC 2021 XPR023 MCF7.311 96H I21 RP9 Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 FIBR027 MCLF130CN 6H C03 pregnenolone 4uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 KDD007 PC3 96H E12 LACZ Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 CPC019 VCAP 24H E21 BRD-K46445327 10uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 REP.A022 MDAMB231 24H M12 zosuquidar 0.04uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 REP.A014 HEK293 24H K22 narlaprevir 0.37uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 KDD003 HT29 96H L13 RFX6 Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC KDB006 A375 96H B16 MARK4 Biosample (Entity type)	A biosample from LINCS produced as part of the L1000 Phase1 project

L1000 LINCS DCIC 2021 PBIOA015 HCC515 24H G18 bortezomib 10uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC XPR002 HELA.311 96H I15 AKT2 2.00uL

Biosample (Entity type)

A biosample from LINCS produced as part of the L1000 Phase2 project

L1000 LINCS DCIC 2021 XPR023 MCF7.311 96H I21 RP9

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 FIBR027 MCLF130CN 6H C03 pregnenolone 4uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 KDD007 PC3 96H E12 LACZ

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 CPC019 VCAP 24H E21 BRD-K46445327 10uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 REP.A022 MDAMB231 24H M12 zosuquidar 0.04uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 REP.A014 HEK293 24H K22 narlaprevir 0.37uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 KDD003 HT29 96H L13 RFX6

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC KDB006 A375 96H B16 MARK4

Biosample (Entity type)

A biosample from LINCS produced as part of the L1000 Phase1 project

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.